PT1975158E - Novos derivados de pirrole com actividade inibidora de histona desacetilase - Google Patents
Novos derivados de pirrole com actividade inibidora de histona desacetilase Download PDFInfo
- Publication number
- PT1975158E PT1975158E PT05850516T PT05850516T PT1975158E PT 1975158 E PT1975158 E PT 1975158E PT 05850516 T PT05850516 T PT 05850516T PT 05850516 T PT05850516 T PT 05850516T PT 1975158 E PT1975158 E PT 1975158E
- Authority
- PT
- Portugal
- Prior art keywords
- histone deacetylase
- deacetylase inhibitor
- inhibitor activity
- pyrrole derivatives
- novel pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/42—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2005/000708 WO2007074176A1 (es) | 2005-12-27 | 2005-12-27 | Nuevos derivados pirrólicos con actividad inhibidora de desacetilasas de histonas |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1975158E true PT1975158E (pt) | 2011-09-23 |
Family
ID=38217700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT05850516T PT1975158E (pt) | 2005-12-27 | 2005-12-27 | Novos derivados de pirrole com actividade inibidora de histona desacetilase |
Country Status (18)
Country | Link |
---|---|
US (1) | US7638550B2 (pt) |
EP (1) | EP1975158B9 (pt) |
JP (1) | JP4975758B2 (pt) |
CN (1) | CN101351444B (pt) |
AT (1) | ATE516268T1 (pt) |
AU (1) | AU2005339535B2 (pt) |
BR (1) | BRPI0520806A2 (pt) |
CA (1) | CA2635392C (pt) |
CY (1) | CY1111899T1 (pt) |
DK (1) | DK1975158T3 (pt) |
ES (1) | ES2369705T3 (pt) |
HK (1) | HK1125926A1 (pt) |
MX (1) | MX2008008470A (pt) |
PL (1) | PL1975158T3 (pt) |
PT (1) | PT1975158E (pt) |
RU (1) | RU2416600C2 (pt) |
SI (1) | SI1975158T1 (pt) |
WO (1) | WO2007074176A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090298905A1 (en) * | 2005-04-15 | 2009-12-03 | Fernando Pedro Cossio | Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof |
EP2305643A1 (en) * | 2009-10-02 | 2011-04-06 | Ikerchem, S.L. | New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
EP2508510A1 (en) * | 2011-04-06 | 2012-10-10 | Ikerchem, S.L. | Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof |
CN103373969B (zh) * | 2012-04-27 | 2015-09-16 | 中国科学院上海有机化学研究所 | 苯基唑环取代酰胺类化合物及其制备方法和用途 |
AU2016267872B2 (en) * | 2015-05-22 | 2019-01-17 | Chong Kun Dang Pharmaceutical Corp. | Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same |
CN106565583A (zh) * | 2016-11-15 | 2017-04-19 | 淮阴师范学院 | 多取代吡咯衍生物的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2273836A1 (en) * | 1996-12-10 | 1998-06-18 | G.D. Searle & Co. | Substituted pyrrolyl compounds for the treatment of inflammation |
JP4191825B2 (ja) * | 1998-09-10 | 2008-12-03 | あすか製薬株式会社 | 5−アミノイソキサゾール誘導体 |
KR20020059393A (ko) * | 1999-09-08 | 2002-07-12 | 제임스 에스. 쿼크 | 새로운 부류의 세포분화제 및 히스톤 데아세틸라아제, 및이의 사용 방법 |
DK1335898T3 (da) * | 2000-09-29 | 2006-04-03 | Topotarget Uk Ltd | Carbaminsyreforbindelser omfattende en amidbinding som HDAC-inhibitorer |
US6576612B1 (en) * | 2000-10-02 | 2003-06-10 | Pharmacia Italia S.P.A. | Antitumor therapy comprising distamycin derivatives |
US7612064B2 (en) | 2003-05-26 | 2009-11-03 | Takeda Pharmaceutical Company Limited | Sulfopyrroles |
EP1691803A1 (en) | 2003-12-05 | 2006-08-23 | Warner-Lambert Company LLC | N-alkyl pyrroles as hmg-coa reductase inhibitors |
EP1725528B1 (en) * | 2004-03-11 | 2013-05-29 | 4Sc Ag | Sulphonylpyrroles as hdac inhibitors |
-
2005
- 2005-12-27 BR BRPI0520806-8A patent/BRPI0520806A2/pt not_active IP Right Cessation
- 2005-12-27 SI SI200531342T patent/SI1975158T1/sl unknown
- 2005-12-27 AT AT05850516T patent/ATE516268T1/de active
- 2005-12-27 CN CN2005800524523A patent/CN101351444B/zh not_active Expired - Fee Related
- 2005-12-27 PT PT05850516T patent/PT1975158E/pt unknown
- 2005-12-27 PL PL05850516T patent/PL1975158T3/pl unknown
- 2005-12-27 EP EP05850516A patent/EP1975158B9/en not_active Not-in-force
- 2005-12-27 MX MX2008008470A patent/MX2008008470A/es active IP Right Grant
- 2005-12-27 DK DK05850516.5T patent/DK1975158T3/da active
- 2005-12-27 JP JP2008547990A patent/JP4975758B2/ja not_active Expired - Fee Related
- 2005-12-27 CA CA2635392A patent/CA2635392C/en not_active Expired - Fee Related
- 2005-12-27 AU AU2005339535A patent/AU2005339535B2/en not_active Ceased
- 2005-12-27 ES ES05850516T patent/ES2369705T3/es active Active
- 2005-12-27 RU RU2008130876/04A patent/RU2416600C2/ru not_active IP Right Cessation
- 2005-12-27 US US10/571,497 patent/US7638550B2/en not_active Expired - Fee Related
- 2005-12-27 WO PCT/ES2005/000708 patent/WO2007074176A1/es active Application Filing
-
2009
- 2009-05-04 HK HK09104096.6A patent/HK1125926A1/xx not_active IP Right Cessation
-
2011
- 2011-10-05 CY CY20111100951T patent/CY1111899T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP4975758B2 (ja) | 2012-07-11 |
CY1111899T1 (el) | 2015-11-04 |
CN101351444B (zh) | 2011-07-13 |
ES2369705T3 (es) | 2011-12-05 |
SI1975158T1 (sl) | 2011-10-28 |
MX2008008470A (es) | 2008-09-26 |
EP1975158B9 (en) | 2012-02-29 |
DK1975158T3 (da) | 2011-10-24 |
US7638550B2 (en) | 2009-12-29 |
EP1975158B1 (en) | 2011-07-13 |
AU2005339535A1 (en) | 2007-07-05 |
JP2009521519A (ja) | 2009-06-04 |
RU2008130876A (ru) | 2010-02-10 |
RU2416600C2 (ru) | 2011-04-20 |
PL1975158T3 (pl) | 2011-12-30 |
BRPI0520806A2 (pt) | 2009-06-09 |
EP1975158A1 (en) | 2008-10-01 |
ATE516268T1 (de) | 2011-07-15 |
WO2007074176A1 (es) | 2007-07-05 |
CN101351444A (zh) | 2009-01-21 |
EP1975158A4 (en) | 2009-11-11 |
HK1125926A1 (en) | 2009-08-21 |
US20080262073A1 (en) | 2008-10-23 |
CA2635392A1 (en) | 2007-07-05 |
CA2635392C (en) | 2013-07-23 |
AU2005339535B2 (en) | 2012-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270215A1 (ru) | Apaf-1 ингибиторные соединения | |
WO2007109178A3 (en) | Indole derivatives as inhibitors of histone deacetylase | |
TW200745047A (en) | Heterocyclic compounds | |
WO2006106326A8 (en) | Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors | |
EA201170531A1 (ru) | Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака | |
EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
WO2010009139A3 (en) | Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors | |
MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
GEP20146060B (en) | Pyridyl inhibitors of hedgehog signalling | |
WO2010011296A3 (en) | Deacetylase inhibitors and uses thereof | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
WO2006063294A3 (en) | Novel inhibitors of histone deacetylase for the treatment of disease | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
BRPI0410727A (pt) | composto, composição farmacêutica, e, uso de um composto | |
ECSP066883A (es) | Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes | |
TW200637817A (en) | 5-aminoindole derivatives | |
HK1125926A1 (en) | Pyrrole derivatives with histone deacetylase inhibitor activity | |
WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
WO2007081808A3 (en) | Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity | |
UA94054C2 (en) | Nitrocatechol derivatives as comt inhibitors |